Milestone Scientific Inc. (MLSS)
NYSEAMERICAN: MLSS · Real-Time Price · USD
0.809
-0.001 (-0.14%)
Nov 4, 2024, 4:00 PM EST - Market closed

Milestone Scientific Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for MLSS stock has a target of 1.25, which predicts an increase of 54.53% from the current stock price of 0.81.

Analyst Consensus: Buy
Target Low Average Median High
Price $1.25 $1.25 $1.25 $1.25
Change +54.53% +54.53% +54.53% +54.53%

Analyst Ratings

According to 1 stock analyst, the rating for MLSS is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Oct '24
Strong Buy 0
Buy 1
Hold 0
Sell 0
Strong Sell 0
Total 1

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Benchmark
Benchmark
Buy
Initiates
$1.25
Buy Initiates $1.25 +54.53% Oct 10, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
9.76M
from 9.83M
Decreased by -0.71%
Revenue Next Year
11.60M
from 9.76M
Increased by 18.88%
EPS This Year
-0.04
from -0.10
EPS Next Year
-0.04
from -0.04
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025
Revenue
8.37M5.44M10.30M8.81M9.83M9.76M11.60M
Revenue Growth
-12.97%-35.07%89.52%-14.54%11.60%-0.71%18.88%
EPS
-0.16-0.12-0.10-0.12-0.10-0.04-0.04
EPS Growth
-------
Forward PE
-------
No. Analysts -----44
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025
High 10.2M 12.4M
Avg 9.8M 11.6M
Low 9.2M 10.7M

Revenue Growth

Revenue Growth 20242025
High
3.6%
27.5%
Avg
-0.7%
18.9%
Low
-5.9%
9.5%

EPS Forecast

EPS 20242025
High -0.04 -0.03
Avg -0.04 -0.04
Low -0.04 -0.05

EPS Growth

EPS Growth 20242025
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.